The US has now obtained enough monkeypox deliveries to administer two jabs to the 1.6 million people identified as being in the high-risk group, writes new agency AP citing a statement from the Biden administration.

The US authorities now expect to have enough doses to administer a second jab towards the end of September, reports AP.

Now the challenge is to ensure that every individual in the high-risk group is vaccinated.

Mainly men who have sex with men make up this group, according to the authorities.

Danish vaccine firm Bavarian Nordic is currently the only drugmaker in the world with an approved monkeypox vaccine.

This has resulted in a slew of orders, which has led the company to upgrade its guidance six times over the course of this year.

On Friday, Bavarian’s share traded 11.7% lower at DKK 317.20 (USD 42). So far the share price has risen by 18% this year and almost 70% since the beginning of June.

Bavarian Nordic: ”We are ready to buy more vaccines”

Merck loses interest in Genmab partner

Moderna says it’s suing Pfizer, Biontech over Covid-19 shots

Audientes books first-ever revenue in H1 but is still far off full-year expectation